Drrx stock forecast.

Bollinger Bands charts for DRRX (Durect Corporation). Bollinger Bands consist of a set of three curves drawn in relation to securities prices.DRRX Stock Performance on November 8, 2023: On November 8, 2023, DRRX stock had a volatile day of trading. The stock opened at $0.83 and traded in a range of $0.58 to $0.83 throughout the day. The trading volume was 693,861 shares. DRRX is a pharmaceutical company based in Cupertino, California, with a market capitalization of $75.3 million.Find the latest CPS Technologies Corporation (CPSH) stock quote, history, news and other vital information to help you with your stock trading and investing.Predictions of DRRX stock price for tomorrow. StockInvest.us is a research service that provides financial data and technical analysis of publicly traded stocks.

According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00.

View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.

Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. ... Latest Stock Analysis. Follow $0.66 0.01 (+1 ...DRRX, Durect - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines. RESEARCH. Shopping Cart. Your cart is ... Durect (DRRX) - Develops pharmaceuticals for chronic pain and central nervous system disorders. GROUP LEADERSHIP Medical-Biomed/Biotech Group. DRRX. is not ranked …Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Get the latest DURECT Corporation (DRRX) stock news and headlines to help you in your trading and investing decisions.The latest Durect stock prices, stock quotes, news, and DRRX history to help you invest and trade smarter. ... Vanguard Total Stock Market ETF: 2.48: Armistice Capital LLC: 2.21: Vanguard Russell ...

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update. Durect Earnings Preview. Track Durect Corp (DRRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.

As of Nov 17, 2023, it costs $0.61 to buy one share of Durect stock. Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.31, you can buy 0.5 shares of DRRX. Get Started with eToro Today. eToro is a multi-asset investment platform.

VINCW. Vincerx Pharma, Inc. 1.6100. -0.4200. -20.69%. In this article, we will take a look at the 10 oversold penny stocks to buy. To see more such companies, go directly to 5 Oversold Penny ...DRRX stock forecast Our latest prediction for Durect Corp's stock price was made on the May 26, 2020 when the stock price was at 2.66$. In the short term (2weeks), DRRX's stock price should outperform the market by 4.58%. During that period the price should oscillate between -11.17% and +17.56%.See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.May 26, 2020 · DRRX stock forecast Our latest prediction for Durect Corp's stock price was made on the May 26, 2020 when the stock price was at 2.66$. In the short term (2weeks), DRRX's stock price should outperform the market by 4.58%. During that period the price should oscillate between -11.17% and +17.56%. DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average …

What this means: InvestorsObserver gives Durect Corp (DRRX) an overall rank of 37, which is below average. Durect Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 37 means that 63% of stocks appear more favorable to our system.17 Oct 2022 ... A few shares may have traded at a slightly higher price on a different day with a lower closing price.) ... DRRX, DURECT, -84%, 2/3/2021. 287 ...Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43 ...May 11, 2023 · Shares of Durect (DRRX) have gained 12.6% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term price targets ... According to the issued ratings of 4 analysts in the last year, the consensus rating for DURECT stock is Moderate Buy based on the current 2 hold ratings and 2 buy ratings for DRRX. The average twelve-month price prediction for DURECT is $34.25 with a high price target of $41.00 and a low price target of $27.00.

Track Durect Corp (DRRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Analyst Forecast. According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,883.61% from the latest price.In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.Durect (DRRX) delivered earnings and revenue surprises of -4% and 41.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts ...View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.

GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.

In trading on Thursday, drugs shares were relative laggards, down on the day by about 0.1%. Helping drag down the group were shares of Durect (DRRX), down about 40.2% and shares of Pain ...

Get the latest DURECT Corporation (DRRX) stock news and headlines to help you in your trading and investing decisions.DRRX: anyone following this stock? It's had quite an amazing run. The OI on the 2.5 dollar jan calls is quite high (much higher than the corresponding puts), and there seems to be two catalysts around the corner with the adcom at Jan 16 as well as the data for Dur-928 due either by the end of this year or early Jan next year. The adcom was ...Nov 30, 2023 · See the latest Durect Corp stock price (DRRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant.Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median... 1 equities research analysts have issued 1 year price targets for Cassava Sciences' shares. Their SAVA share price targets range from $11.00 to $124.00. On average, they predict the company's share price to reach $54.33 in the next year. This suggests a possible upside of 154.5% from the stock's current price.According to the National Snow & Ice Data Center, blizzard prediction relies on modeling weather systems, as well as predicting temperatures. The heavy snowfall that blizzards create can be hard to predict in advance.Oct 19, 2023 · The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. The forecasts range from a low of $32.32 to a high of $38.85. ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K ... The firm increased its portfolio allocation in DRRX by 30. ...Based on 2 Wall Street analysts offering 12 month price targets for Biolase in the last 3 months. The average price target is $4.00 with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 244.83% change from the last price of $1.16. Highest Price Target $4.00. Average Price Target $4.00. Oct 15, 2020 · The Durect stock forecast is 1.3653368157524 USD for 2024 November 26, Tuesday; and 6.830 USD for 2028 November 26, Sunday with technical analysis. Durect (DRRX) stock price prediction is 1.3653368157524 USD. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...

DURECT (NASDAQ:DRRX) stock price plunges 31% as it entered into definitive agreements for the purchase and sale of an aggregate of 2.99M shares of common stock and warrants to purchase up to 2.99M ...A high-level overview of DURECT Corporation (DRRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Durect Corp (NASDAQ:DRRX) has a beta value of 1.29 and has seen 1.24 million shares traded in the last trading session. The company, currently valued at $14.51M, closed the last trade at $0.53 per share which meant it -0.87% during that session. The DRRX stock price is -1692.45% off its 52-week high ...Instagram:https://instagram. fx demo accountwhere to preorder iphone 15best investment bankingaugmented reality stock View the latest Lakeland Financial Corp. (LKFN) stock price, news, historical charts, analyst ratings and financial information from WSJ.Cascades deeply regrets and is saddened to announce the death of one of its cofounders, Mr. Bernard Lemaire, at the age of 87. Find the latest Cascades Inc. (CAS.TO) stock quote, history, news and other vital information to help you with your stock trading and investing. forex traders that trade for youvusux Nov 24, 2023 · Analyst Forecast According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,430.30% from the latest price. moo moo review Jun 7, 2023 · On June 7, 2023, DURECT Corporation announced the successful completion of enrollment for Phase 2b AHFIRM clinical trial. The trial DURECT (DRRX) Stock Forecast & Price Target $0.64 +0.01 (+1.03%) (As of 02:51 PM ET) Compare Today's Range $0.59 $0.65 50-Day Range $0.53 $2.98 52 …